Sandbox:Mitra: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
{{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}}
{{familytree | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|-|.| |}}
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}}
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| |}}
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 |B01=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Reperfusion'''|B02=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Maintenance of RV preload'''|B03=<div style="float: center; text-align: center; width: 5em; padding:1em;">'''Decrease RV afterload'''|B04=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Restoring Rate/Rhythm and AV synchrony'''|B05=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Inotropic support'''|B06=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Mechanical Circulatory Support'''}}
{{familytree | | | B01 | | | B02 | | | B03 | | B04 | | B05 | | | B06 |B01=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Reperfusion'''|B02=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Maintenance of [[RV]] [[preload]]'''|B03=<div style="float: center; text-align: center; width: 5em; padding:1em;">'''Decrease RV afterload'''|B04=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Restoring [[Rate]]/[[Rhythm]] and AV synchrony'''|B05=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''Inotropic support'''|B06=<div style="float: Center; text-align: Center; width: 5em; padding:1em;">'''[[Mechanical Circulatory Support]]'''}}
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | |}}
{{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | |}}
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | | C06 |C01=<div style="float: Center; text-align: Center; width: 5em; padding:2em;"> •'''Thrmobolytics''' <br> •'''Percutaneous coronary intervention (PCI)''' <br>
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | | C06 |C01=<div style="float: Center; text-align: Center; width: 5em; padding:2em;"> •'''Thrmobolytics''' <br> •'''[[Percutaneous coronary intervention]] ([[PCI]])''' <br>
|C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload reducing agents''', such as:<br>
|C02= <div style="float: Center; text-align: left;"> • '''Avoidance of preload-reducing agents''', such as:<br>
:❑Nitrates
:❑ [[Nitrates]]
:❑Diuretics
:❑ [[Diuretics]]
:❑Morphin
:❑ [[Morphin]]
• '''In patients with hypotension (without pulmonary congestion):
• '''In patients with [[hypotension]] (without [[pulmonary congestion]]):
:❑ Intravenous administration of Fluids (N/S 0.9% at 40mL for 2L, to maintain CVP <15mmHg and PCWP between 18-24 mmHg)
:❑ Intravenous administration of Fluids (N/S 0.9% at 40mL for 2L, to maintain [[CVP]] <15 mmHg and [[PCWP]] between 18-24 mmHg)
|C03=<div style="float: Center; text-align: left;"> • '''Systemic or pulmonary vasodilators:'''<br>  
|C03=<div style="float: Center; text-align: left;"> • '''Systemic or pulmonary [[vasodilators]]:'''<br>  
:❑Nitrosrusside
:❑ [[Nitrosrusside]]
:❑Inhaled nitric oxide
:❑ Inhaled [[nitric oxide]]
|C04=<div style="float: Center; text-align: left;"> • '''In patients with bradyarrhthmias:'''<br>  
|C04=<div style="float: Center; text-align: left;"> • '''In patients with [[bradyarrhthmias]]:'''<br>  
:❑Atropine
:❑ [[Atropine]]
:❑Pacemaker
:❑ [[Pacemaker]]
• '''In patients with atrioventricular block:'''<br>  
• '''In patients with atrioventricular block:'''<br>  
:❑Temporary dual-chamber pacemaker
:❑ Temporary dual-chamber [[pacemaker]]
|C05=<div style="float: Center; text-align: left;"> '''In patients with refractory hypotension:'''<br>   
|C05=<div style="float: Center; text-align: left;"> '''In patients with refractory [[hypotension]]:'''<br>   
:❑Dobutamine (along with fluids)
:❑ [[Dobutamine]] (along with fluids)
:❑Other inotropes:
:❑ Other [[inotropes]]:
*milrinone
* [[Milrinone]]
*norepinephrine
* [[Norepinephrine]]
|C06= <div style="float: Center; text-align: left;"> • '''May be needed in patients with cardiogenic shock secondary to RVMI''':
|C06= <div style="float: Center; text-align: left;"> • '''May be needed in patients with [[cardiogenic shock]] secondary to [[RVMI]]''':
:❑Direct RV support
:❑ Direct RV support
:❑Indirect RV support
:❑ Indirect RV support
:❑Biventricular support}}
:❑ Biventricular support}}
<br><br>
<br><br>
{{familytree/end}}
{{familytree/end}}

Revision as of 16:02, 4 August 2020



 
 
 
 
 
 
 
 
 
 
 
 
Therapuetic Considerations in RVMI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reperfusion
 
 
Maintenance of RV preload
 
 
Decrease RV afterload
 
Restoring Rate/Rhythm and AV synchrony
 
Inotropic support
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thrmobolytics
Percutaneous coronary intervention (PCI)
 
 
Avoidance of preload-reducing agents, such as:
Nitrates
Diuretics
Morphin

In patients with hypotension (without pulmonary congestion):

❑ Intravenous administration of Fluids (N/S 0.9% at 40mL for 2L, to maintain CVP <15 mmHg and PCWP between 18-24 mmHg)
 
 
Systemic or pulmonary vasodilators:
Nitrosrusside
❑ Inhaled nitric oxide
 
In patients with bradyarrhthmias:
Atropine
Pacemaker

In patients with atrioventricular block:

❑ Temporary dual-chamber pacemaker
 
In patients with refractory hypotension:
Dobutamine (along with fluids)
❑ Other inotropes:
 
 
May be needed in patients with cardiogenic shock secondary to RVMI:
❑ Direct RV support
❑ Indirect RV support
❑ Biventricular support




Do's

Don'ts